Tech & Gadgets

The Apple Watch helps AFib patients avoid blood thinners in a groundbreaking study

A hospital in Pittsburgh has become the latest medical center to participate in a groundbreaking Apple Watch study in the US that is helping patients with atrial fibrillation get off blood-thinning medications.

The REACT-AF study began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of all participants) wear an Apple Watch 14 hours a day, linked to an iPhone that is pre-programmed to monitor irregular heart rhythms.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button